SOURCE: Event Cardio Group Inc

November 19, 2014 10:30 ET

Event Cardio Group Acquires Worldwide Rights to Now Cardio™, Advanced Cardiac Monitoring Device

NEW YORK, NY--(Marketwired - Nov 19, 2014) - Event Cardio Group, Inc. (OTCQB: ECGI), a medical device company, announced it has finalized its acquisition of full intellectual property (IP) and development rights for Now Cardio™, advanced cardiac monitoring device.

On Nov. 14, 2014, the Company finalized the acquisition of the intellectual property, production, and distribution rights for Now Cardio™, an advanced cardiac monitor device which offers dual-functionality including both holter monitoring, and event recording simultaneously, which the Company believes to be the first of its' kind. As a wireless and leadless system, it is more comfortable to wear, and as a result, is more likely to be worn.

Current cardiac monitoring suffers from patients failing to wear their monitoring devices. Diagnostic yield from the data collected from current holter monitors is as low as 4%, but research shows event recorders diagnostic yields are currently 62%, and the Company believes we can exceed 90%, and thus save more lives through early detection.

Breast Cancer Detection Device

The Company has also obtained an agreement with Life Medical Technologies, Inc. with respect to their "BreastCare DTS™ device", which grants exclusive right to distribute the BreastCare DTS™ in the United States, Canada and certain countries in Asia, and certain rights throughout the rest of the world.

FDA Approval

BreastCare DTS™ has received FDA 510K clearance for marketing in the United States to be used by physicians as an adjunct to routine physical examination including palpation, mammography and other established procedures for the detection of breast disease including breast cancer.

Now with licensing agreement in place for BreastCare DTS™, and the rights for Now Cardio™ now under the ECGI umbrella, the company's full attention will now turn towards commercialization and production, with pending updates on that front expected shortly.

About Event Cardio Group, Inc.

Event Cardio Group, Inc., is a developer of medical diagnostic detection equipment that focuses on the detection, and preventive treatment, of high-risk diseases. The Company's core products are their Now Cardio™, an advanced cardiac monitor which offers dual-functionality including both holter monitoring and event recording simultaneously, and FDA approved BreastCare DTS™ breast cancer detection device. For more information on the company please visit

Safe Harbor Statement

Information included in this press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). This information may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Sunrise Holdings Limited ("Sunrise", "We", "Our" or the "Company") to be materially different from future results, performance or achievements expressed or implied by any forward-looking statements. Forward-looking statements, which involve assumptions and describe our future plans, strategies and expectations, are generally identifiable by use of words "may," "should," "expect," "anticipate," "estimate," "believe," "intend" or "project" or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are based on assumptions that may be incorrect, and there can be no assurance that any projections or other expectations included in any forward-looking statements will come to pass. Our actual results could differ materially from those expressed or implied by the forward-looking statements as a result of various factors. Except as required by applicable laws, the Company undertakes no obligation to update publicly any forward-looking statements for any reason, even if new information becomes available or other events occur in the future.

Contact Information

  • Contact

    Melissa Diaz
    South Street Media, Inc.
    (917) 937-8968
    Email Contact

    John Bentivoglio
    Event Cardio Group
    President and CEO
    Email Contact